SUBSCRIBE
SUBSCRIBE
News   Drug Development

VGX Pharmaceuticals (Formerly Known as Viral Genomix, Inc.)’ Oral Anti-Inflammatory Drug Safe in Phase I Study

March 26, 2009 | 
1 min read
Clinical research Phase I
MORE ON THIS TOPIC
IN PARTNERSHIP WITH TRUVETA
Webinar: AI for Faster, More Precise Real-World Research: Extracting Clinical Notes Data at Scale
August 27, 2025
 · 
1 min read
 · 
BioSpace Insights
A pit crew working on a race car
Regulatory
The US Is Losing Its Biopharma Edge, Writes Former FDA Commissioner
August 27, 2025
 · 
3 min read
 · 
Dan Samorodnitsky
Contemporary art collage of target and hands with the megaphone on a ue background with copy space. Concept of reaching a goal and spreading.
Rare diseases
Regeneron Eyes 2026 Filing for siRNA Myasthenia Gravis Drug After Phase III Win
August 27, 2025
 · 
2 min read
 · 
Tristan Manalac
Podcast
Lilly’s Obesity Pill Heads to the FDA, AbbVie Bets on Psychedelics, HHS Unveils More Change
August 27, 2025
 · 
1 min read
 · 
Jef Akst